摘要 |
This invention provides a method of reducing the damaging effect of CNS white matter injury (including traumatic CNS injury, anoxia, and ischemia) to mammalian CNS tissue, particularly spinal cord tissue, by <i>in vivo</i> treatment thereof with inhibitors of excitatory amino acid transporters, such as the Na<+>-dependent glutamate transporter and pharmaceutical compositions comprising said inhibitors.
|